Moolec Science SAMLECEarnings & Financial Report
Moolec Science SA is a global agricultural biotechnology and food technology company specializing in molecular farming. It uses engineered crop platforms to produce sustainable, cost-competitive animal-derived proteins for use in alternative meat, dairy products and food ingredients, serving food manufacturers, agribusinesses and consumer goods brands across North America, Europe and Latin America.
MLEC Q2 2025 Key Financial Metrics
Revenue
$2.6M
Gross Profit
$-674.4K
Operating Profit
$-2.1M
Net Profit
$-2.4M
Gross Margin
-25.5%
Operating Margin
-77.9%
Net Margin
-91.8%
YoY Growth
N/A
EPS
$-0.06
Financial Flow
Moolec Science SA Q2 2025 Financial Summary
Moolec Science SA reported revenue of $2.6M for Q2 2025, with a net profit of $-2.4M (-91.8% margin). Cost of goods sold was $3.3M, operating expenses totaled $1.4M.
Key Financial Metrics
| Total Revenue | $2.6M |
|---|---|
| Net Profit | $-2.4M |
| Gross Margin | -25.5% |
| Operating Margin | -77.9% |
| Report Period | Q2 2025 |
Moolec Science SA Quarterly Revenue & Net Profit History
Moolec Science SA results over the last 2 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q2 2025 | $2.6M | — | $-2.4M | -91.8% |
| Q1 2024 | $1.7M | — | $-1.6M | -91.4% |
Income Statement
| Q1 2024 | Q2 2025 | |
|---|---|---|
| Revenue | $1.7M | $2.6M |
| YoY Growth | N/A | N/A |
Balance Sheet
| Q1 2024 | Q2 2025 | |
|---|---|---|
| Assets | $22.5M | $31.4M |
| Liabilities | $13.6M | $28.6M |
| Equity | $8.9M | $2.8M |
Cash Flow
| Q1 2024 | |
|---|---|
| Operating CF | $-1.7M |